METAVIA INC. Financing Cash Flow
METAVIA INC. (MTVA) reported Financing Cash Flow of $10.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- METAVIA INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $2.67M, a 71.86% decline year-over-year.
- METAVIA INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $7.71M.
- METAVIA INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $861.00K.
- METAVIA INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$357.00K.
- METAVIA INC. net cash provided by (used in) financing activities for fiscal 2025 was $9.96M, a 45.55% decline from fiscal 2024.
- METAVIA INC. net cash provided by (used in) financing activities for fiscal 2024 was $18.30M.
- METAVIA INC. net cash provided by (used in) financing activities for fiscal 2023 was -$80.00K, a 100.28% decline from fiscal 2022.
- METAVIA INC. net cash provided by (used in) financing activities for fiscal 2022 was $28.68M, a 30.21% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.38M 10-Q · filed 2026-08-06 | $11.24M derived: sum of 3 quarters · filed 2026-08-06 | $10.88M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $7.71M 10-Q · filed 2026-05-14 | $8.57M derived: sum of 2 quarters · filed 2026-05-14 | $8.21M derived: sum of 3 quarters · filed 2026-05-14 | $17.69M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $861.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $504.00K derived: sum of 2 quarters · filed 2026-03-26 | $9.98M derived: sum of 3 quarters · filed 2026-08-06 | $9.96M 10-K · filed 2026-03-26 | |||
| 2025-09-30 | -$357.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.12M derived: sum of 2 quarters · filed 2026-08-06 | $9.10M 10-Q · filed 2025-11-06 | $8.92M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $9.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.46M 10-Q · filed 2026-08-06 | $9.28M derived: sum of 3 quarters · filed 2026-08-06 | $8.56M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$12.00K 10-Q · filed 2026-05-14 | -$195.00K derived: sum of 2 quarters · filed 2026-05-14 | -$912.00K derived: sum of 3 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$900.00K derived: sum of 2 quarters · filed 2026-03-26 | $18.30M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | -$717.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $18.48M 10-Q · filed 2025-11-06 | $18.52M 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | $19.20M 10-Q · filed 2025-08-07 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | -$80.00K 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$80.00K 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | -$80.00K 10-Q · filed 2024-08-14 | ||||||
| 2022-12-31 | $28.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $28.68M 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | -$134.00K 10-Q · filed 2023-11-13 | ||||||
| 2021-12-31 | $12.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $12.86M derived: sum of 2 quarters · filed 2023-03-30 | $12.93M derived: sum of 3 quarters · filed 2023-03-30 | $22.03M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $48.00K derived: sum of 2 quarters · filed 2022-11-14 | $9.14M 10-Q · filed 2022-11-14 | $9.14M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $9.16M 10-Q · filed 2022-08-12 | $9.16M derived: sum of 3 quarters · filed 2022-08-12 | $9.16M derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $9.09M 10-Q · filed 2022-05-13 | $9.09M derived: sum of 2 quarters · filed 2022-05-13 | $9.09M derived: sum of 3 quarters · filed 2022-05-13 | $15.90M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $6.80M derived: sum of 3 quarters · filed 2022-03-31 | $6.86M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $6.80M derived: sum of 2 quarters · filed 2021-11-15 | $6.86M 10-Q · filed 2021-11-15 | $6.86M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $6.86M 10-Q · filed 2021-08-16 | $6.86M derived: sum of 3 quarters · filed 2021-08-16 | $6.85M derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | $53.00K 10-Q · filed 2021-05-17 | $54.00K derived: sum of 2 quarters · filed 2021-05-17 | $45.00K derived: sum of 3 quarters · filed 2021-05-17 | $34.48M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | -$8.00K derived: sum of 2 quarters · filed 2021-04-15 | $34.43M derived: sum of 3 quarters · filed 2021-04-15 | $24.17M 10-K · filed 2021-04-15 | |||
| 2019-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $34.42M derived: sum of 2 quarters · filed 2020-11-13 | $24.17M 10-Q · filed 2020-11-13 | -$10.26M 10-Q · filed 2019-11-08 | $18.28M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | $34.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $24.18M 10-Q · filed 2020-08-11 | -$10.26M 10-Q · filed 2019-08-09 | $18.29M derived: sum of 3 quarters · filed 2020-08-11 | $18.34M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | -$10.26M 10-Q · filed 2019-05-09 | -$16.14M derived: sum of 2 quarters · filed 2020-03-30 | -$16.09M derived: sum of 3 quarters · filed 2020-03-30 | -$16.24M derived: sum of 4 quarters · filed 2020-03-30 | |||
| 2018-12-31 | -$5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$5.83M derived: sum of 2 quarters · filed 2020-03-30 | -$5.98M derived: sum of 3 quarters · filed 2020-03-30 | $17.25M 10-K · filed 2020-03-30 | $22.39M 10-K · filed 2019-03-18 | ||
| 2018-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$93.00K derived: sum of 2 quarters · filed 2019-11-08 | $23.13M 10-Q · filed 2019-11-08 | $23.02M derived: sum of 4 quarters · filed 2019-11-08 | |||
| 2018-06-30 | -$144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $23.08M 10-Q · filed 2019-08-09 | $22.97M derived: sum of 3 quarters · filed 2019-08-09 | $33.12M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $23.22M 10-Q · filed 2019-05-09 | $23.12M derived: sum of 2 quarters · filed 2019-05-09 | $33.27M derived: sum of 3 quarters · filed 2019-05-09 | $33.09M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | -$107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $10.04M derived: sum of 2 quarters · filed 2019-03-18 | $9.87M derived: sum of 3 quarters · filed 2019-03-18 | $21.34M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $10.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $9.98M derived: sum of 2 quarters · filed 2018-11-08 | $21.45M 10-Q · filed 2018-11-08 | $20.73M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-06-30 | -$172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $11.30M 10-Q · filed 2018-08-14 | $10.59M derived: sum of 3 quarters · filed 2019-03-18 | $37.76M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-03-31 | $11.47M 10-Q · filed 2018-05-08 | $10.76M derived: sum of 2 quarters · filed 2019-03-18 | $37.94M derived: sum of 3 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | -$713.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $26.46M derived: sum of 2 quarters · filed 2019-03-18 | $31.46M 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | $27.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $32.17M 10-Q · filed 2017-11-13 | |||||
| 2016-06-30 | $4.99M 10-Q · filed 2017-08-14 | ||||||
| 2015-12-31 | $8.74M 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |